.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Cerilliant
Federal Trade Commission
Boehringer Ingelheim
US Army
UBS
QuintilesIMS
Queensland Health
Chubb

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021952

« Back to Dashboard
NDA 021952 describes CLARITIN, which is a drug marketed by Bayer Healthcare Llc and is included in seven NDAs. It is available from four suppliers. There is one patent protecting this drug. Additional details are available on the CLARITIN profile page.

The generic ingredient in CLARITIN is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.

Summary for 021952

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021952

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARITIN
loratadine
CAPSULE;ORAL 021952 NDA Bayer HealthCare LLC. 11523-7200 11523-7200-1 1 BLISTER PACK in 1 CARTON (11523-7200-1) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
CLARITIN
loratadine
CAPSULE;ORAL 021952 NDA Bayer HealthCare LLC. 11523-7200 11523-7200-6 3 BLISTER PACK in 1 CARTON (11523-7200-6) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 16, 2008TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Novartis
Fish and Richardson
US Army
Medtronic
Accenture
Daiichi Sankyo
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot